Dave Muoio

The Series A round will help the Salt Lake City startup solidify its role as an end-to-end patient-billing suite.

The recently announced COVID-19 Open Research Dataset consists of more than 29,000 machine-readable coronavirus articles ripe for analysis.

The company's hybrid in-person and virtual visit approach provides consumers with male hormone replacement therapies and other supplements.

Also: Welltok expands to Latin America with insurer partnership; Kyruus and GYANT combine their offerings for health system clients.

New hires, branding efforts and academic research partnerships are all on the table for the smart ring maker's future.

First announced by President Trump on Friday as a nationwide resource, the testing-referral service already seems to have reached its capacity among California's Santa Clara and San Mateo counties.

The iRhythm Technologies founder's new startup will use these funds to wrap up clinical testing of its device, and push toward a commercial launch.

Also: Consumer survey suggests declining digital health engagement; Iran's COVID-19 app pulled from Play Store after malware accusations.

The funds will help the New York City-based platform extend its growth and deliver new product offerings.

Livongo Health, Hinge Health, Hello Heart, Torchlight and Whil each underwent "rigorous clinical, data security and business evaluation" for inclusion in the program.